Skip to Content

CYP 269 (Guaifenesin and Phenylephrine Hydrochloride 600 mg / 20 mg)

Pill with imprint CYP 269 is White, Elliptical / Oval and has been identified as Guaifenesin and Phenylephrine Hydrochloride 600 mg / 20 mg. It is supplied by Cypress Pharmaceutical Inc.

Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 600 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CYP 269

Guaifenesin and phenylephrine hydrochloride 600 mg / 20 mg CYP 269 Front
Guaifenesin and phenylephrine hydrochloride 600 mg / 20 mg CYP 269 Back

Guaifenesin and Phenylephrine Hydrochloride

Imprint
CYP 269
Strength
600 mg / 20 mg
Color
White
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cypress Pharmaceutical Inc
National Drug Code (NDC)
60258-0269

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.